Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Meds Catalog

Glucosamine

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog partial Not FDA-approved for animals Novipet, Inc. Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Catalog refreshed
May 5, 2026, 10:05 a.m.

Roxee has a partial storefront projection for this medication. Some primary facts still need verification.

FDA applications
FDA application data refreshed
May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
May 5, 2026, 10:01 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: April 15, 2026

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Image coming soon
Glucosamine

Glucosamine

Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals

Both 81% storefront ready

Species: Both

Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Glucosamine

Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus. Species commonly shown: Both.

Generic name
Glucosamine
Brand names
Novipet
Manufacturer
Novipet, Inc.
Species
Both
Completeness
81%
Validation
Incomplete
Brand names
Novipet

Indications / Uses

Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus.

Side Effects

Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Death by euthanasia, Seizure NOS, Decreased appetite.

FAQ

Both

Source Transparency

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Roxee still has limited plain-language guidance for this medication. Use the official documents and your veterinarian's instructions for product-specific details.

Used for:

Your vet decides this. Here's what owners typically ask/watch for.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • wobbly/unsteady walking (1 reports)
  • Heart murmur (1 reports)
  • Head shake - behavioural disorder (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • wobbly/unsteady walking
  • Heart murmur
  • Head shake - behavioural disorder

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Heart murmur (1 reports)
  • Head shake - behavioural disorder (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Novipet, Inc.
Identifiers:
NDC Package: 16244-1004-1 NDC Package: 45732-013-30 NDC Package: 45732-013-60 NDC Package: 45732-075-10 NDC Package: 73309-352-01 NDC Product: 16244 NDC Product: 45732 NDC Product: 73309

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
26
Species represented
2
Grouped by Body System
Digestive (2) · Loss of appetite, Diarrhea Neurologic (2) · Unsteady walking (ataxia), Circling - neurological disorder Behavior (2) · Head shake - behavioural disorder, Biting -aggression Other (26) · Heart murmur, Head down, Falling
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Other 1 Cat 1
Behavior 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1

Species coverage: Dog (19) Cat (13)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Serious - 1
Digestive Cat Non-serious - 1
Other Cat Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Digestive Cat Non-serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Cat Non-serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Neurologic Dog Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Behavior Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Source metadata:

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

1

FOI

0
No FOI links yet.

Novipet SPL

SPL · Structured Product Label

Open original
FDA Structured Product Label XML for Novipet. Use the source link for the full official labeling record.
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Novipet
Manufacturer mapping: Novipet, Inc.
Case-reported brands (openFDA): MSK
Catalog species: Both
NDC: Packages 45732-075-10 • Products 45732
Safety (openFDA)
Top reactions: Dog 40 • Cat 15 • View
Case summaries: 9 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Top reaction signals
Unsteady walking (ataxia) (1) Heart murmur (1) Head shake - behavioural disorder (1) Head down (1) Falling (1) Eosinopenia (1) Elevated symmetrical dimethylarginine (1) Elevated serum alkaline phosphatase (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NDC Package: 16244-1004-1 NDC Package: 45732-013-30 NDC Package: 45732-013-60 NDC Package: 45732-075-10 NDC Package: 73309-352-01 NDC Product: 16244 NDC Product: 45732 NDC Product: 73309
Package NDC Product NDC Form / Route Status
16244-1004-1 16244 -
45732-013-30 45732 -
45732-013-60 45732 -
45732-075-10 45732 -
73309-352-01 73309 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

  • Novipet SPL • Structured Product Label • Official
    FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 28 Clinical 7 Manufacturer 0 Marketing 0
Current Field Facts
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Death by euthanasia, Seizure NO… (Clinical, 2026-04-11)
  • manufacturer_name: Novipet, Inc. (Official, 2026-05-05)
  • manufacturer_name: Novipet, Inc. (Official, 2026-05-03)
  • manufacturer_name: Novipet, Inc. (Official, 2026-05-02)
  • manufacturer_name: Novipet, Inc. (Official, 2026-04-29)
  • manufacturer_name: Novipet, Inc. (Official, 2026-04-28)
  • manufacturer_name: Novipet, Inc. (Official, 2026-04-27)
  • manufacturer_name: Novipet, Inc. (Official, 2026-04-26)
  • manufacturer_name: Novipet, Inc. (Official, 2026-04-25)
  • manufacturer_name: Novipet, Inc. (Official, 2026-04-22)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Death by euthanasia, Seizure NO… (Official, 2026-05-05)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Death by euthanasia, Seizure NO… (Official, 2026-05-03)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Death by euthanasia, Seizure NO… (Official, 2026-04-30)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Diarrhoea, Death by euthanasia, Seizure NO… (Official, 2026-04-29)
Recent Revisions
  • side_effects updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-26 10:06 by etl_backfill • Backfilled from existing medication fields
  • side_effects updated 2026-04-25 10:05 by etl_backfill • Backfilled from existing medication fields
  • monitoring updated 2026-04-21 10:07 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-21 10:07 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-21 10:07 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-21 10:07 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-21 10:07 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-21 10:07 by curated_loader • Official FDA application reference for Senvelgo.
  • monitoring updated 2026-04-20 10:08 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-20 10:08 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-20 10:08 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-20 10:08 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-20 10:08 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-20 10:08 by curated_loader • Official FDA application reference for Senvelgo.

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published

Data source: FDA Animal Drugs @ FDA (public search export).

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Cat Diarrhea (1) • Cat

Showing top 5 for Digestive.

Neurologic
Unsteady walking (1) • Dog Circling - neurological disorder (1) • Dog

Showing top 5 for Neurologic.

Behavior
Head shake - behavioural disorder (1) • Dog Biting -aggression (1) • Dog

Showing top 5 for Behavior.

Other
Heart murmur (1) • Cat Head down (1) • Dog Falling (1) • Dog Eosinopenia (1) • Dog Elevated symmetrical dimethylarginine (1) • Dog
Show more (21)
Elevated serum alkaline phosphatase (1) • Cat Elevated lipase (1) • Dog Elevated blood urea nitrogen (1) • Dog Elevated aspartate aminotransferase (1) • Cat Elevated alanine aminotransferase (1) • Cat Disorder of red blood cell NOS (1) • Dog Discomfort NOS (1) • Dog Defect Unknown/Not Specified (1) • Cat Death by euthanasia (1) • Dog Cough (1) • Cat Confusion (1) • Dog Collapse NOS (1) • Dog Chronic kidney disease (1) • Cat Cardiac disorder NOS (1) • Cat Bone and joint disorder NOS (1) • Dog Arrhythmia (1) • Cat Arched back (1) • Dog Anaemia NOS (1) • Dog Abnormal ultrasound finding (1) • Cat Abnormal radiograph finding (1) • Dog Abnormal cytology (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Retriever - Labrador, Male, 5 year, 39.463 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Limb non-weight bearing, Bone and joint disorder NOS, Other abnormal test result NOS, Abnormal radiograph finding, Urinary tract obstruction/blockage… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-074601
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.00 Year
  • Weight: 39.463 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Limb non-weight bearing Bone and joint disorder NOS Other abnormal test result NOS Abnormal radiograph finding Urinary tract obstruction/blockage Discomfort NOS Walking difficulty Death by euthanasia Osteochondritis dissecans Urolithiasis
Outcomes: Euthanized

Dog, Shih Tzu, Female, 14 year, 6.35 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Malaise, Not himself/herself, Confusion, Sleepiness - systemic disorder, Arched back… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-072769
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 14.00 Year
  • Weight: 6.350 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Malaise Not himself/herself Confusion Sleepiness - systemic disorder Arched back Falling Collapse NOS Intervertebral disc disease Head down Paralysis Vocalisation Not defecating Pain NOS Head shake - behavioural disorder Rotatory nystagmus Death by euthanasia
Outcomes: Euthanized

Dog, Shih Tzu, Male, 14.83 year, 7.076 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Renal failure, Weight loss, Seizure NOS, Vocalisation, Anaemia NOS… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-072872
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.83 Year
  • Weight: 7.076 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Renal failure Weight loss Seizure NOS Vocalisation Anaemia NOS Hypertension Hepatomegaly Circling - neurological disorder Urolithiasis Death by euthanasia Hyperkalaemia Shaking Elevated blood urea nitrogen Elevated alanine aminotransferase Elevated serum alkaline phosphatase Abnormal radiograph finding Elevated symmetrical dimethylarginine
Outcomes: Euthanized

Dog, ['Retriever (unspecified)', 'Dog (unknown)'], Female, 13 year, 38.555 kilogram • Drug: MSK, Unknown • Reactions: Urinary incontinence • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-070900
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Female
  • Age: 13.00 Year
  • Weight: 38.555 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Urinary incontinence
Outcomes: Ongoing

Cat, Domestic Shorthair, Male, 6 year, 5.352 kilogram • Drug: MSK, Oral, Dose: 1 tablet per animal • Reactions: Chronic kidney disease • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-072139
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 6.00 Year
  • Weight: 5.352 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 1 tablet per animal
Reactions Reported:
Chronic kidney disease
Outcomes: Outcome Unknown

Dog, Dog (unknown), Male, 11 year, 19.3 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Musculoskeletal disorder NOS, Walking difficulty • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-070411
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 11.00 Year
  • Weight: 19.300 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Musculoskeletal disorder NOS Walking difficulty
Outcomes: Ongoing

Cat, Siberian, Female, 15 year, 5.4 kilogram • Drug: MSK, Oral • Reactions: Vomiting, Defect Unknown/Not Specified • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-072611
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 15.00 Year
  • Weight: 5.400 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
Reactions Reported:
Vomiting Defect Unknown/Not Specified
Outcomes: Recovered/Normal

Cat, Domestic Shorthair, Male, 14 year, 5.262 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Localised pain NOS, Wobbliness, Not eating, Anaemia NOS, Elevated alanine aminotransferase… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-068717
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.00 Year
  • Weight: 5.262 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Localised pain NOS Wobbliness Not eating Anaemia NOS Elevated alanine aminotransferase Arrhythmia Heart murmur Abnormal radiograph finding Abnormal ultrasound finding Hepatomegaly Cardiac disorder NOS Liver tumour
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.